Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance
Ingrid M. Ariës,
Rosanna E. van den Dungen,
Marco J. Koudijs,
Edwin Cuppen,
Emile Voest,
Jan J. Molenaar,
Huib N. Caron,
Rob Pieters,
Monique L. den Boer
Affiliations
Ingrid M. Ariës
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam
Rosanna E. van den Dungen
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam
Marco J. Koudijs
Department of Medical Genetics, University Medical Center Utrecht;Center for Personalized Cancer Treatment
Edwin Cuppen
Department of Medical Genetics, University Medical Center Utrecht;Center for Personalized Cancer Treatment
Emile Voest
Department of Medical Genetics, University Medical Center Utrecht;Center for Personalized Cancer Treatment
Jan J. Molenaar
Department of Human Genetics, Academic Medical Centre, University of Amsterdam;Individualized Therapies for Children with Cancer Study Group
Huib N. Caron
Department of Human Genetics, Academic Medical Centre, University of Amsterdam;Individualized Therapies for Children with Cancer Study Group
Rob Pieters
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam;Individualized Therapies for Children with Cancer Study Group;Dutch Childhood Oncology Group, The Hague, The Netherlands
Monique L. den Boer
Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam;Individualized Therapies for Children with Cancer Study Group;Dutch Childhood Oncology Group, The Hague, The Netherlands
